The latest Eclipse Theia release isn’t the kind of announcement that arrives with fireworks, sweeping claims, or a promise to reinvent software development by lunchtime. That’s probably a good thing.

Sangamo Therapeutics, a pioneering gene editing biotech company in the Bay Area, has filed for Chapter 11 bankruptcy protection and agreed to sell some of its programs and platforms to Eli Lilly and ...

Graham Kates is an investigative reporter covering criminal justice, privacy issues and information security for CBS News Digital. Contact Graham at [email protected] or [email protected] ...